NCT06385171 Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
| NCT ID | NCT06385171 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Global Aesthetics LLC |
| Condition | Wrinkle |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-05-22 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-05-22 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
Eligibility Criteria
Inclusion Criteria: * Individuals of both genders. * Must be in good physical health. * Age between 20 and 65 years. * Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region. * Must possess the willingness and ability to understand and provide informed consent, as well as effectively communicate with study personnel. Exclusion Criteria: * Pregnant or breastfeeding female. * Age below 20 or above 65 years. * History of neuromuscular disorders, such as myasthenia gravis. * History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study. * Recent treatment history within the past 6 months in the forehead or glabellar region, including: * Ablative laser procedures. * Radiofrequency device treatments. * Ultrasound device treatments. * Medium to deep chemical peels. * Temporary soft tissue augmentation. * Semi-permanent soft tissue augmentation within the past 2 years. * Permanent soft tissue augmentation. * Planned cosmetic procedures within the next 6 months in the same region. * Intended use of tretinoin or retinoic acid within the next 6 months. * Presence of active infection in the treated area, excluding mild acne. * Allergy to cow's milk protein or albumin. * Use of aminoglycoside medications. * Current use of anticoagulation therapy. * History of bleeding disorders. * Diagnosis of mental illness. * Inability to comprehend the study protocol or provide informed consent.
Contact & Investigator
Otis Scroggins, BS, CNA
PRINCIPAL INVESTIGATOR
Global Aesthetics LLC
Frequently Asked Questions
Who can join the NCT06385171 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Wrinkle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06385171 currently recruiting?
Yes, NCT06385171 is actively recruiting participants. Contact the research team at fakefaceaesthetics@gmail.com for enrollment information.
Where is the NCT06385171 trial being conducted?
This trial is being conducted at Cisco, United States, Lubbock, United States.
Who is sponsoring the NCT06385171 clinical trial?
NCT06385171 is sponsored by Global Aesthetics LLC. The principal investigator is Otis Scroggins, BS, CNA at Global Aesthetics LLC. The trial plans to enroll 500 participants.